Perspective · 10 Sep 2026
Conference abstractPublished 20 Jul 2015
Interleukin (IL)-8 early predictor of mortality following trauma hemorrhagic shock
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Trauma injury and hemorrhagic shock frequently leads to the imbalance of immune system known as Systemic Inflammatory Response Syndrome (SIRS) and is connected to the morbidity or mortality. Pro and Anti-inflammatory, which play a significant role in the development of multiple organ failure (MOF). Objective: This study investigates the serum cytokines levels in patients with trauma hemorrhagic shock and the association of these cytokines with clinical outcome. Design: Prospective cohort study Patients: A total 70 patients with trauma hemorrhagic shock admitted to the emergency department, level 1trauma centre. Method: Peripheral blood samples were collected in each patient for determination of serum cytokines concentration. Samples were obtained within 8 h of post injury with T/HS patients. Standard resuscitation techniques as per Advance Trauma Life Support were used in each patient. Clinical and laboratory data were prospectively collected. Results: High concentrations of circulating IL-6, IL-10, IL-8, IL-12, (p< 0.05) were detected in a trauma hemorrhagic shock as compared with healthy control group. At study entry, IL-8 concentrations were higher in non-survivors as compared with survivors T/HS patients but not TNF-α, IL-1 β, IL6, IL10. Increased IL-8 value was an indicator of mortality in patients with trauma hemorrhagic shock. Conclusions: In trauma hemorrhagic shock, increased IL-6, IL-10, IL-8, IL-12 are detected while compared to normal healthy control. In these patients, increased IL-8 value in nonsurvivors as compared to survivors and TNF-α, IL-1 β, IL6, IL10 do not correlate with clinical outcome. This study suggests a much higher degree of activation of immune-inflammatory in T/HS than in normal healthy control. Increased IL-8 values were found to be reliable markers of mortality following T/HS.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Manoj Kumar”
- BylineArticles whose byline prints “D N Rao”
- BylineArticles whose byline prints “Sujata Mohanty”
- BylineArticles whose byline prints “Arul Selvi”
- BylineArticles whose byline prints “Sanjeev K Bhoi”
